Judge Rules RFK Jr. Overreached on Gender-Affirming Care Restrictions
Objective Facts
On March 20, 2026, a federal judge in Oregon ruled that Health and Human Services Secretary Robert F. Kennedy Jr. has overreached in his push to restrict gender-affirming care for minors. Judge Mustafa Kasubhai, an appointee of former President Biden, found that Kennedy did not adhere to proper administrative procedures when he declared in December that gender-affirming health care was "neither safe nor effective." Judge Kasubhai ruled that Health Secretary Robert F. Kennedy Jr. didn't go through the proper administrative procedures in December when issuing the declaration, which warned doctors that they could be excluded from federal health programs like Medicare and Medicaid if they provide these treatments. Twenty-one states, including Oregon and New York, filed the lawsuit, as well as the District of Columbia. The ruling grants preliminary relief to health professionals who provide the treatments. The judge also denied the government's motion to dismiss the case.
Left-Leaning Perspective
Left-leaning outlets and LGBTQ+ advocacy organizations framed the ruling as a decisive victory against federal overreach and protection of medical autonomy. Democratic New York Attorney General Letitia James said in a statement: "Today's win breaks through the noise and gives some needed clarity to patients, families, and providers. Health care services for transgender young people remain legal, and the federal government cannot intimidate or punish the providers who offer them." The states argued the directive was not grounded in established medical science and represented an attempt to coerce providers by threatening federal funding and regulatory consequences. The states noted the declaration contradicted the consensus of major medical organizations, including the American Academy of Pediatrics and the American Medical Association, which recognize gender-affirming care as evidence-based and, in many cases, medically necessary. Left-leaning outlets situated this ruling within a broader pattern of Trump administration restrictions on LGBTQ+ rights. Coverage noted this "follows the wider pattern of anti-LGBTQ+ bills and actions that have been taken since Trump's inauguration. Since being sworn-in as the 47th president of the United States, Trump has enacted a series of anti-LGBTQ+ executive orders, many of which specifically target the trans community."
Right-Leaning Perspective
Right-leaning outlets reported the ruling but emphasized the judge's appointment by Biden and the Trump administration's legal argument that the declaration was merely non-binding opinion. The Washington Examiner reported that lawyers for the federal government argued in court filings that the declaration did not create a binding policy, "Instead, they said it merely reflected Kennedy's personal assessment of disputed and evolving medical treatments." The outlet noted that plaintiffs had allegedly "misunderstood" the purpose of the declaration, "describing it as a nonbinding statement of the secretary's views based on his reading of medical literature." Newsmax and other right-leaning outlets reported the blocking but did not provide extensive editorial commentary defending or criticizing the judge's reasoning on the merits. The available search results do not reveal prominent conservative figures or outlets offering substantive counter-arguments to the judge's ruling or defending RFK Jr.'s medical claims.
Deep Dive
This case exposes a fundamental tension between executive power, administrative procedure, and federalism in the Trump administration's effort to reshape health policy. RFK Jr.'s December declaration attempted to override state and medical professional standards by declaring gender-affirming care unsafe—a move that threatened to strip funding from hospitals, particularly those in Democratic-led states that protect the practice in their Medicaid programs. Judge Kasubhai's ruling hinges on a procedural defect: the HHS Secretary circumvented the Administrative Procedure Act's requirement for public notice and comment before substantively changing healthcare policy. This is not, strictly speaking, a ruling on the merits of gender-affirming care itself; it is a ruling that the executive exceeded its authority by the method it chose. The government's argument that the declaration was mere opinion—no different from Kennedy's right to publish commentary—fails because it was issued by a federal secretary whose pronouncements carry enforcement consequences through the Office of Inspector General's authority to exclude providers from federal programs. What each side gets right and misses: Left-leaning critics correctly identify that the declaration, though technically non-binding, functioned as de facto binding policy—hospitals across the country limited or halted gender-affirming care in response, creating a chilling effect. The government's semantic distinction between "opinion" and "policy" collapses when the secretary's opinion triggers investigatory and exclusion proceedings. However, left-leaning sources do not deeply engage with the substantive medical debate: the HHS report cited some legitimate concerns about evidence gaps and adolescent consent to irreversible treatments, issues that are not frivolous even if major U.S. medical organizations currently endorse gender-affirming care. The right, for its part, emphasizes the procedural separation between declaration and enforcement, a legally defensible argument, but in available coverage does not robustly defend the factual claims in the HHS report or explain why current medical standards should be questioned. The right also does not grapple with why, if the declaration was truly non-binding opinion, 17 hospitals felt compelled to cease treatment pending investigation. What to watch next: The judge promised a written opinion, which will provide detail on reasoning and may shape the scope of any appeal. The Trump administration will likely pursue an appeal or attempt to issue a properly procedure-compliant rule change. Parallel proposed regulations that would directly bar Medicare and Medicaid payments to any hospital providing gender-affirming care to minors remain pending and may face separate legal challenges. Meanwhile, 27 Republican-led states have enacted bans on gender-affirming care, creating a patchwork in which the federal ruling does not constrain state-level restrictions. The broader question—whether gender-affirming care is ultimately safe and appropriate for minors—will persist in medical, political, and judicial arenas regardless of procedural outcomes. This ruling slows federal override of state and medical professional judgment but does not resolve the underlying medical and moral dispute.